Prostate Cancer - Results from #25100

Advances in imaging and in non-surgical salvage treatments after radiorecurrence in prostate cancer: What does the oncologist, radiotherapist and radiologist need to know? - Abstract August 20, 2012

Quality-of-life effects of prostate-specific antigen screening - Abstract August 20, 2012

Increased survival with Enzalutamide in prostate cancer after chemotherapy - Abstract August 20, 2012

Serum α-tocopherol and γ-tocopherol concentrations and prostate cancer risk in the PLCO Screening Trial: A nested case-control study - Abstract August 20, 2012

Risk-adaptive volumetric modulated arc therapy using biological objective functions for subvolume boosting in radiotherapy - Abstract August 20, 2012

Focal therapy of prostate cancer: Energies and procedures - Abstract August 20, 2012

Long-term survival and toxicity in patients treated with high-dose intensity modulated radiation therapy for localized prostate cancer - Abstract August 20, 2012

Relationship of imaging frequency and planning margin to account for intrafraction prostate motion: Analysis based on real-time monitoring data - Abstract August 20, 2012

Prostate carcinogenesis with diabetes and androgen-deprivation-therapy-related diabetes: An update - Abstract August 17, 2012

Risk communication and prostate cancer: Identifying which summary statistics are best understood by men - Abstract August 17, 2012

Reduced-dose docetaxel for castration-resistant prostate cancer has no inferior impact on overall survival in Japanese patients - Abstract August 17, 2012

Comparative effectiveness of external-beam radiation approaches for prostate cancer - Abstract August 17, 2012

Association of healthcare barriers with prostate-specific antigen screening among African-American and Afro-Caribbean men - Abstract August 17, 2012

Permanent implantation as brachytherapy technique for prostate carcinoma- review of clinical trials and guidelines - Abstract August 17, 2012

Impact of surgical margin status on prostate-cancer-specific mortality - Abstract August 17, 2012

Prediction of survival benefit using an automated bone scan index in patients with castration-resistant prostate cancer - Abstract August 17, 2012

Dietary fatty acid intake and prostate cancer survival in Orebro County, Sweden - Abstract August 17, 2012

Phase 3, randomized, placebo-controlled study of zibotentan (ZD4054) in patients with castration-resistant prostate cancer metastatic to bone - Abstract August 17, 2012

Transrectal sonoelastography in the detection of prostate cancers: A meta-analysis - Abstract August 17, 2012

Combination immunotherapy with prostate GVAX and ipilimumab: Safety and toxicity - Abstract August 17, 2012

Page 1256 of 1437